$448.7M in CY2024 Part D spend354K claims · 89K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Atogepant used for?
Atogepant is a Calcitonin Gene-related Peptide Receptor Antagonist medication tracked in Medicare Part D.
Is there a generic for Atogepant?
No. Atogepant is brand-only with no generic equivalents currently in market.
How much does my plan pay for Atogepant?
Across 329 Part D plans, Atogepant averages $38.42/unit (NADAC). Lowest available: $38.37/unit. Highest in distribution: $38.47/unit.
Is Atogepant on the FDA shortage list?
No. Atogepant is not currently on the FDA Drug Shortage Database.
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (3 approvals on file) · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.